One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis

Camille V. Edwards, Divaya Bhutani, Markus Mapara, Jai Radhakrishnan, Sofia Shames, Mathew S. Maurer, Siyang Leng, Jonathan Wall, Alan Solomon, Andrew Eisenberger, Suzanne Lentzsch

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)115-116
Number of pages2
JournalAmyloid
Volume26
Issue numbersup1
DOIs
StatePublished - Mar 29 2019

Fingerprint

Amyloidosis
Monoclonal Antibodies

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Edwards, C. V., Bhutani, D., Mapara, M., Radhakrishnan, J., Shames, S., Maurer, M. S., ... Lentzsch, S. (2019). One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis. Amyloid, 26(sup1), 115-116. https://doi.org/10.1080/13506129.2019.1584892

One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis. / Edwards, Camille V.; Bhutani, Divaya; Mapara, Markus; Radhakrishnan, Jai; Shames, Sofia; Maurer, Mathew S.; Leng, Siyang; Wall, Jonathan; Solomon, Alan; Eisenberger, Andrew; Lentzsch, Suzanne.

In: Amyloid, Vol. 26, No. sup1, 29.03.2019, p. 115-116.

Research output: Contribution to journalLetter

Edwards, CV, Bhutani, D, Mapara, M, Radhakrishnan, J, Shames, S, Maurer, MS, Leng, S, Wall, J, Solomon, A, Eisenberger, A & Lentzsch, S 2019, 'One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis', Amyloid, vol. 26, no. sup1, pp. 115-116. https://doi.org/10.1080/13506129.2019.1584892
Edwards, Camille V. ; Bhutani, Divaya ; Mapara, Markus ; Radhakrishnan, Jai ; Shames, Sofia ; Maurer, Mathew S. ; Leng, Siyang ; Wall, Jonathan ; Solomon, Alan ; Eisenberger, Andrew ; Lentzsch, Suzanne. / One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis. In: Amyloid. 2019 ; Vol. 26, No. sup1. pp. 115-116.
@article{86df665dc8574458a83d341831641e88,
title = "One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis",
author = "Edwards, {Camille V.} and Divaya Bhutani and Markus Mapara and Jai Radhakrishnan and Sofia Shames and Maurer, {Mathew S.} and Siyang Leng and Jonathan Wall and Alan Solomon and Andrew Eisenberger and Suzanne Lentzsch",
year = "2019",
month = "3",
day = "29",
doi = "10.1080/13506129.2019.1584892",
language = "English (US)",
volume = "26",
pages = "115--116",
journal = "Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis",
issn = "1350-6129",
publisher = "Informa Healthcare",
number = "sup1",

}

TY - JOUR

T1 - One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis

AU - Edwards, Camille V.

AU - Bhutani, Divaya

AU - Mapara, Markus

AU - Radhakrishnan, Jai

AU - Shames, Sofia

AU - Maurer, Mathew S.

AU - Leng, Siyang

AU - Wall, Jonathan

AU - Solomon, Alan

AU - Eisenberger, Andrew

AU - Lentzsch, Suzanne

PY - 2019/3/29

Y1 - 2019/3/29

UR - http://www.scopus.com/inward/record.url?scp=85069705307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069705307&partnerID=8YFLogxK

U2 - 10.1080/13506129.2019.1584892

DO - 10.1080/13506129.2019.1584892

M3 - Letter

VL - 26

SP - 115

EP - 116

JO - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

JF - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

SN - 1350-6129

IS - sup1

ER -